Literature DB >> 12358806

Prostaglandin H2 (PGH2) accelerates formation of amyloid beta1-42 oligomers.

Olivier Boutaud1, Joyce J Ou, Pierre Chaurand, Richard M Caprioli, Thomas J Montine, John A Oates.   

Abstract

Epidemiologic evidence implicates cyclooxygenase activity in the pathogenesis of Alzheimer's disease, in which amyloid plaques have been found to contain increased levels of dimers and higher multimers of the amyloid beta peptide. The product of the oxygenation of arachidonic acid by the cyclooxygenases, prostaglandin H2 (PGH2), rearranges non-enzymatically to several prostaglandins, including the highly reactive gamma-keto aldehydes, levuglandins E2 and D2. We demonstrate that PGH2 markedly accelerates the formation of dimers and higher oligomers of amyloid beta1-42. This is associated with the formation of levuglandin adducts of the peptide. These findings provide the molecular basis for a hypothesis linking cyclooxygenase activity to the formation of oligomers of amyloid beta.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12358806     DOI: 10.1046/j.1471-4159.2002.01064.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  27 in total

Review 1.  The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease.

Authors:  Sam Gandy
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

2.  Membrane-mediated amyloidogenesis and the promotion of oxidative lipid damage by amyloid beta proteins.

Authors:  Ian V J Murray; Liu Liu; Hiroaki Komatsu; Kunihiro Uryu; Gang Xiao; John A Lawson; Paul H Axelsen
Journal:  J Biol Chem       Date:  2007-01-24       Impact factor: 5.157

Review 3.  Therapeutic targets in prostaglandin E2 signaling for neurologic disease.

Authors:  P J Cimino; C Dirk Keene; Richard M Breyer; Kathleen S Montine; Thomas J Montine
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

4.  PGH2-derived levuglandin adducts increase the neurotoxicity of amyloid beta1-42.

Authors:  Olivier Boutaud; Thomas J Montine; Lei Chang; William L Klein; John A Oates
Journal:  J Neurochem       Date:  2006-01-12       Impact factor: 5.372

5.  Pyridoxamine analogues scavenge lipid-derived gamma-ketoaldehydes and protect against H2O2-mediated cytotoxicity.

Authors:  Sean S Davies; Eric J Brantley; Paul A Voziyan; Venkataraman Amarnath; Irene Zagol-Ikapitte; Olivier Boutaud; Billy G Hudson; John A Oates; L Jackson Roberts
Journal:  Biochemistry       Date:  2006-12-06       Impact factor: 3.162

6.  Determination of 3-methoxysalicylamine levels in mouse plasma and tissue by liquid chromatography-tandem mass spectrometry: application to in vivo pharmacokinetics studies.

Authors:  Irene Zagol-Ikapitte; Venkataraman Amarnath; Satyawan Jadhav; John A Oates; Olivier Boutaud
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2011-03-21       Impact factor: 3.205

7.  Molecular Structures of Isolevuglandin-Protein Cross-Links.

Authors:  Wenzhao Bi; Geeng-Fu Jang; Lei Zhang; John W Crabb; James Laird; Mikhail Linetsky; Robert G Salomon
Journal:  Chem Res Toxicol       Date:  2016-09-21       Impact factor: 3.739

Review 8.  Isolevuglandin adducts in disease.

Authors:  Robert G Salomon; Wenzhao Bi
Journal:  Antioxid Redox Signal       Date:  2015-02-18       Impact factor: 8.401

9.  Formation of gamma-ketoaldehyde-protein adducts during ethanol-induced liver injury in mice.

Authors:  Sanjoy Roychowdhury; Megan R McMullen; Michele T Pritchard; Wei Li; Robert G Salomon; Laura E Nagy
Journal:  Free Radic Biol Med       Date:  2009-07-17       Impact factor: 7.376

10.  Increased isolevuglandin-modified proteins in glaucomatous astrocytes.

Authors:  Bharathi Govindarajan; Anna Junk; Mabel Algeciras; Robert G Salomon; Sanjoy K Bhattacharya
Journal:  Mol Vis       Date:  2009-06-01       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.